Department of Justice June 2, 2017 – Federal Register Recent Federal Regulation Documents

Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of Currently Approved Collection #1121-0277: OJJDP National Training and Technical Assistance Center (NTTAC) Feedback Form Package
Document Number: 2017-11410
Type: Notice
Date: 2017-06-02
Agency: Department of Justice
The Department of Justice, Office of Justice Programs has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection was previously published in the Federal Register on March 28, 2017 allowing for a 60-day comment period.
Agency Information Collection Activities; Proposed eCollection; eComments Requested; Extension With or Without Change, of a Previously Approved Collection: Drug Questionnaire (DEA-341)
Document Number: 2017-11409
Type: Notice
Date: 2017-06-02
Agency: Department of Justice
Department of Justice (DOJ), Drug Enforcement Administration will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. This proposed information collection was previously published in the Federal Register on March 28, 2017, allowing for a 60-day comment period.
Schedules of Controlled Substances: Temporary Placement of Acryl Fentanyl Into Schedule I
Document Number: 2017-11215
Type: Proposed Rule
Date: 2017-06-02
Agency: Drug Enforcement Administration, Department of Justice
The Administrator of the Drug Enforcement Administration is issuing this notice of intent to issue a temporary order to schedule the synthetic opioid, N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryl fentanyl or acryloylfentanyl), into Schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act. This action is based on a finding by the Administrator that the placement of this synthetic opioid into Schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. When it is issued, the temporary scheduling order will impose the administrative, civil, and criminal sanctions and regulatory controls applicable to Schedule I controlled substances under the Controlled Substances Act on the manufacture, distribution, reverse distribution, possession, importation, exportation, research, and conduct of instructional activities, and chemical analysis of this synthetic opioid.